Imagen Molecular de Alta Sensibilidad (IMAS)

IMAS (highly sensitive molecular imaging) is a recent project in which i3M is actively participating. In the IMAS project, there are two scintillation technologies working towards the ultimate goal: the development of a high-performance Total-Body PET scanner. The two technologies are liquid-xenon and crystal scintillators. The DMIL group is working on novel detectors based on crystal scintillators, together with accurate simulation and reconstruction tools.

IMAS will open up new venues in diagnostic imaging enabling several medical imaging breakthroughs: Imaging babies, dynamic and simultaneous studies of several organs, imaging longer and faster, imaging tumour heterogeneity, non-malignant diseases imaging, etc.

The IMAS project “Imagen Molecular de Alta Sensibilidad (IMAS)” has been launched by the Conselleria de Sanitat Universidad and Salut Publica from the Generalitat Valenciana.​ The project runs under the framework of the FID Health Program from the Ministerio de Ciencia, Innovacion y Universidades, with a total budget of 7.500.000 €, 50% co-funded by the FEDER funds.

DMIL is working with three companies based in our region: Full Body Insight, Quibim and Oncovision